Skip to main content
Download PDF

The V protein in oncolytic Newcastle disease virus promotes HepG2 hepatoma cell proliferation at the single-cell level

BMC Cancer volume 23, Article number: 346 (2023) Cite this article

Abstract

Background

Newcastle disease virus (NDV) is an oncolytic virus that can inhibit cancer cell proliferation and kill cancer cells. The NDV nonstructural V protein can regulate viral replication; however, whether the V protein contributes to NDV oncolysis is unclear.

Results

This study revealed that NDV inhibited tumor cell proliferation and that V protein expression promoted the proliferation of HepG2 cells, as determined at the single-cell level. In addition, to identify the regulatory mechanism of the V protein in HepG2 cells, transcriptome sequencing was performed and indicated that the expression/activation of multiple cell proliferation-related genes/signaling pathways were changed in cells overexpressing the V protein. Hence, the MAPK and WNT signaling pathways were selected for verification, and after blocking these two signaling pathways with inhibitors, the V protein promotion of cell proliferation was found to be attenuated.

Conclusions

The results showed that the V protein regulated the proliferation of cancer cells through multiple signaling pathways, providing valuable references for future studies on the mechanism by which the V protein regulates cancer cell proliferation.

Peer Review reports

Introduction

Newcastle disease virus (NDV) is an oncolytic virus in the Paramyxoviridae family. NDV replicates in human tumor cells but largely fails to replicate in noncancerous human cells [1], which causes the virus to selectively kill cancer cells. NDV is an enveloped virus with a negative-strand RNA genome that encodes six structural viral proteins: nucleocapsid protein (NP), phosphoprotein (P), matrix protein (M), fusion protein (F), hemagglutinin-neuraminidase (HN), and large polymerase protein (L). These genes are arranged in the genome in the following order: 3′-NP-P-M-F-HN-L-5′. Moreover, NDV encodes two nonstructural proteins, V and W, which are produced by RNA editing during P gene transcription [2].

Among the viral structural proteins, NP encapsulates genomic RNA and binds to the P and L proteins to form ribonucleoprotein complexes (RNPs), which are templates for viral genome transcription and replication [3]. HN is critical for activating the F protein and forming a complex that mediates membrane fusion [4], and the M protein is required for fusion and release of nucleocapsid into the host cytoplasm [5]. In addition, NDV nonstructural proteins, particularly the V protein, play important roles in viral replication. V protein can target the IFN signaling pathway; however, type I IFN signaling is impaired, and whether the V protein can regulate viral replication in tumor cells remains to be determined.

During oncolysis, NDVs are toxic to human tumor cell lines of ecto-, endo-, and mesodermal origin, and the cytotoxicity induced by these NDV strains in tumor cells is related to multiple caspase-dependent pathways of apoptosis, which are activated independent of IFN signaling [6]. In general, apoptosis of host cells can inhibit viral replication, and the V protein is known for its antiapoptotic activity [7,8,9]. In our previous study, we showed that the V protein can activate MEK/ERK signaling in HeLa cells [10]. Another study showed that the V protein can upregulate cytokine signaling 3 expression, and cytokine signaling 3 overexpression in chicken embryo fibroblast cells can activate the MEK/ERK signaling pathway [11]. ERK is critical for the activation of several downstream molecules, many of which directly affect cell proliferation, survival and differentiation [12], and an increasing number of studies have suggested that MEK/ERK is a therapeutic target in human cancer [13]. Whether the V protein can regulate cancer cell proliferation is still unknown.

The present study evaluated the possible mechanisms underlying the antiapoptotic effects of the V protein, and the results suggested that the V protein may be involved in regulating cancer cell proliferation. Moreover, the role played by the V protein in regulating cancer cell proliferation was confirmed, and the results indicated that the V protein can activate multiple signaling pathways to promote cancer cell replication.

Results

NDV inhibits HepG2 cell proliferation

To determine the effect of NDV on cell proliferation at the single-cell level, we first infected HepG2 cells with NDV at a multiplicity of infection (MOI) of 1 for 24 h and then added 10 nM EdU to the cells and incubated these treated cells for 1 h. Then, the cells were subjected to immunofluorescence and EdU analyses, and the results showed that the proportion of EdU-positive and GFP-positive cells was significantly lower than the proportion of GFP-negative cells (Fig. 1A). Then, another dish of HepG2 cells was infected with NDV (MOI of 1) for 48 h, followed by immunofluorescence and EdU analyses (Fig. 1B). The single-cell level results were similar to those obtained after NDV infection for 24 h and suggested that NDV inhibited cell proliferation.

Fig. 1
figure 1

NDV inhibits cell proliferation at the single-cell level. HepG2 cells were infected with NDV. Then, 24 h (A) and 48 h (B) postinfection, the cells were labeled with EdU (10 nM) for 1 h and then stained with chicken anti-NDV serum and goat anti-chicken IgY Alexa Fluor® 488 (green) secondary antibodies. EdU staining was carried out according to the EdU manufacturer’s instructions. Nuclei were stained with Hoechst 33,342. Images were captured using a Leica fluorescence microscope (400 ×); bar = 50 μm

Full size image

The V protein promotes HepG2 cell proliferation

To confirm the function of the V protein in cell proliferation, we overexpressed the V protein in HepG2 cells. Western blot (Fig. 2A and Supplementary Fig. 1) and immunofluorescence (Fig. 2B-C) analyses showed that the V protein was overexpressed in HepG2 cells. After transfection with pCAGEN-Flag-V for 24 h (Fig. 2B) or 48 h (Fig. 2C), 10 nM EdU was added and incubated for 1 h. The immunofluorescence and EdU analyses revealed more V protein-positive cells than V protein-negative cells. To verify this finding at the general level, we used a real-time label-free cell recorder to detect cell proliferation, and the results showed that the V protein promoted cell proliferation (Fig. 2D). These results suggested that the V protein enhanced HepG2 proliferation. However, compared with detection at 48 h after overexpression of the V protein (* P < 0.05), the effect of the V protein on promoting cell proliferation was more significant at 24 h (* * P < 0.01).

Fig. 2
figure 2

The V protein promotes cell proliferation at the single-cell level. HepG2 cells were transfected with pCAGEN-Flag-V (to overexpress the V protein). WB results showed that V protein was successfully overexpressed A. After 24 h (B) and 48 h (C), the cells were labeled with EdU (10 nM) for 1 h and then stained with rabbit anti-Flag antibody and goat anti-rabbit IgG Alexa Fluor.® 488 (green) secondary antibody. For EdU staining, the steps were carried out according to the EdU manufacturer’s instructions. Nuclei were subsequently stained with Hoechst 33,342. Images were captured with a Leica fluorescence microscope (400 ×); bar = 50 μm. The results of the unlabeled cell recorder showed that the number index of cells in the overexpression of V protein group was significantly higher than that in the control group (E)

Full size image

Gene expression changes induced by the V protein

To determine the gene expression difference between the V protein overexpression group and the control group, sequencing was performed, and the results showed that the expression of genes was increased/downregulated (Fig. 3A). The green circle indicates the control group, and the red circle indicates the V protein overexpression group. A total of 561 genes were specifically expressed in V protein-overexpressing cells, and 501 genes were specifically expressed in control cells (Fig. 3B). qRT–PCR with β-actin as the reference revealed that the expression of the cell proliferation-related genes FOS and RRBP1 was increased and that the expression of ERLEC1 and LMAN1 was decreased (Fig. 3C-F); these results were consistent with the sequencing results.

Fig. 3
figure 3

Differentially expressed genes (DEGs) in HepG2 cells overexpressing the V protein. RNA sequencing (RNA-seq) analyses of three independent experiments were repeated. A Volcano map showing differences in genetic transcription in HepG2 cells 48 h after transfection with pCAGEN-Flag-V. B Venn diagram analysis was performed to identify the genes with expression regulated through V protein overexpression. (C-H) qPCR detection of changes in gene expression after V protein overexpression. *P < 0.05

Full size image

V protein through a variety of different signaling pathways to regulate cell proliferation

An ingenuity pathway analysis showed significant changes in signaling pathways following V protein expression, and the 20 most significantly changed pathways are shown (Fig. 4A). NDV is a single-stranded negative-stranded RNA virus. Among the enriched pathways, herpes simplex virus 1 infection, viral carcinogenesis and RNA transport are closely related to viral cycle life, and changes in these signaling pathways suggested that the V protein plays a regulatory role in the viral life cycle. However, prior to this study, whether the V protein regulates cell proliferation, which affects changes in the cell cycle, was unknown. This study suggests a strategy for exploring the mechanism by which the V protein regulates cell proliferation. A total of 166 cell cycle-related genes were in the cell cycle signaling pathway (Fig. 4B). After V protein overexpression, the expression of most of these genes was increased, and they are marked in red (Fig. 4B). These results further demonstrate that the V protein can regulate cell proliferation.

Fig. 4
figure 4

Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways showing enriched differentially expressed genes (DEGs). A The KEGG pathways with the most significantly enriched DEGs. B, RNA sequencing (RNA-seq) results showed the relationship and expression changes of 166 cell cycle-related genes after overexpression of the V protein in HepG2 cells

Full size image

The V protein can regulate cell proliferation through multiple pathways

Many signaling pathways regulate cell proliferation. Although RNA-seq showed that the cell cycle was affected, no specific signaling pathways associated with cell proliferation regulation were enriched with the identified DEGs. Therefore, the mechanism through which the V protein regulates cell proliferation remains unclear. The MAPK and WNT signaling pathways are classical signaling pathways that affect cell proliferation, and variable genes caused by overexpression of V protein are partially concentrated in MAPK and WNT signaling pathways (Supplementary table). To verify that these signaling pathways affected the proliferation of cells after the V protein was overexpressed, we first used the ERK1/2 inhibitors U0126 (100 nM) and IWR-1 (200 nM) to examine the role played by the ERK1/2 and WNT pathways in HepG2 proliferation. The EdU results showed a reduction in the number of EdU-positive cells (red fluorescence) after treatment with 100 nM U0126 or 200 nM IWR-1 for 24 h compared with the control group (Fig. 5A).

Fig. 5
figure 5

The MAPK and ERK1/2 signaling pathway inhibitor U0126 and WNT/β-catenin signaling pathway inhibitor IWR-1 interfere with the effect of V protein on cell proliferation. A After 6 h, U0126- and IWR-1-treated cells were labeled with EdU (10 nM) and incubated for 1 h. The EdU staining steps were carried out according to the EdU manufacturer’s instruction manual. Nuclei were subsequently stained with Hoechst 33,342, and EdU-positive cell percentages are shown on the right. HepG2 cells were transfected with pCAGEN-Flag-V (to overexpress the V protein). After 24 h (A), U0126 (B) or IWR-1 (C) was added to cells, which were incubated for another 6 h, followed by labeling with EdU (10 nM) and incubation for 1 h. Then, the cells were stained with rabbit anti-Flag antibody and goat anti-rabbit IgG Alexa Fluor® 488 (green) secondary antibody. For EdU staining, the steps were carried out according to the EdU manufacturer’s instructions. Nuclei were subsequently stained with Hoechst 33,342. Images were captured using a Leica fluorescence microscope (400 ×), bar = 50 μm

Full size image

Then, to verify that the changes in these two signaling pathways affected cell proliferation because of V protein expression, plasmids (pCAGEN-Flag-V) overexpressing the V protein were transfected into HepG2 cells, and inhibitors were added 24 h after transfection. For the cells treated for 12 h, EdU and immunofluorescence staining analysis showed that both U0126 and IWR-1 (Fig. 5 B) inhibited cell proliferation, as determined at the single-cell level. These results indicated that both signaling pathways affected cell proliferation through the action of the V protein. Hence, it is suggested that the V protein regulates cell proliferation through multiple mechanisms.

Discussion

This study demonstrated at the single-cell level that NDV inhibited the proliferation of cancer cells; however, the V protein of NDV promoted the proliferation of cancer cells. These findings suggested that oncolytic NDV viral proteins may be involved in reducing the oncolytic effect, which provides a new perspective on oncolytic viruses.

NDV infects poultry, which can affect bursa development and can proliferate in susceptible chicken lines [14]. Dendritic cells bridge innate and adaptive immunity and regulate host resistance to viral invasion. When NDV infects mice, dendritic cells inhibit the proliferation of T cells [15]. In TC-1 cervical cancer cells, NDV reduced the apoptosis rate and suppressed cell growth [16].

Abdullah et al. [17] wrote a review on the abnormal proliferation and aggressive invasion behavior of GBM, which had been reported to be associated with aberrant Rac1 protein signaling. Notably, NDV interacts with Rac1 upon viral entry, syncytium induction, and actin reorganization in an infected cell during the replication process.

NDV potentially led to reactive oxygen species production in a dose-dependent manner, which might have led to NDV action against cervical cancer cell proliferation [18]. As an oncolytic virus, NDV affects cell proliferation, which is of interest. Our previous preliminary work showed, at the single-cell level, that NDV selectively infected dividing cells, which promoted NDV replication [19].

Our present study performed at the single-cell level showed that NDV infection resulted in cell proliferation inhibition, which may be detrimental to viral replication. However, we also found that at different times (24 h and 48 h) after NDV infection, there were proportional differences in the effect of the V protein on cell proliferation, suggesting that NDV may engage in other dynamic mechanisms to affect cell proliferation. Perhaps this difference gradually decreases with the extension of time, suggesting that V protein may promote cell proliferation at an early stage.

Vaccinia virus (VACV) has been reported to alter cell cycle regulation and trigger the host cell DNA damage response. Caroline K. Martin et al. concluded that VACV modulates host cell proliferation and host cell cycle progression through temporal expression of multiple VACV effector proteins [20]. The effects of the transactivator Tas encoded by foamy viruses and expressed after cell cycle arrest or before apoptosis highlight the different mechanisms through which virus–host interactions inhibit cell proliferation [21]. Encephalomyocarditis virus 2A protein inhibited apoptosis [22], and human papilloma virus 16 (HPV16) protein E7 increased PKM2 expression and activated the nonglycolytic function of PKM2 to promote cervical cancer cell proliferation [23]. However, no direct evidence has shown to date that the V protein encoded by NDV regulates host cell proliferation; however, our present work shows that the V protein promotes cancer cell proliferation.

Many mechanisms affect cell proliferation [24]. In this study, we demonstrated at the single-cell level that the V protein promoted cell proliferation. Transcriptome sequencing revealed the mechanism by which the V protein promotes cell proliferation. Namely, we found that the V protein activates/silences multiple genes in HepG2 cells and that these genes are enriched in multiple signaling pathways. This is the first study to perform RNA-seq to identify a signaling pathway through which the V protein regulates cell proliferation.

The MEK/ERK signaling pathway regulates cancer cell proliferation, apoptosis, inflammation, angiogenesis, metastasis and drug resistance. In our previous work, we found that the V protein promotes viral replication in HeLa cells through the activation of the MEK/ERK signaling pathways [10]. Moreover, NDV selectively infects dividing cells and promotes viral proliferation [19], and these previous studies suggest that viral proteins may regulate viral replication by affecting cell proliferation. In the present study, our results demonstrate that the V protein regulates cell proliferation through the ERK signaling pathway.

Similar to the MEK/ERK signaling pathway, the Wnt signaling pathway exhibits diverse functions. It is involved in an evolutionarily conserved cell-to-cell coordination mechanism and is crucial for a variety of physiological processes in an organism's body, including stem cell regeneration, proliferation, division, and migration; cell polarity and fate determination; and specification of neural crest, neural symmetry and morphogenesis [25]. For certain endogenous retroviruses, differential gene expression analysis of various TCGA datasets has revealed a link between HEMO expression and activation of the Wnt/β-catenin signaling pathway, particularly in endometrial cancer [26]. Wnt/beta-catenin signaling is activated in HPV ( +) cervicovaginal cells, and activation of the Wnt/beta-catenin signaling pathway may predispose organisms with early gene-encoded cellular factors to HPV infection [27]. However, the mechanism by which the V protein regulates cancer cell proliferation through the Wnt/beta-catenin signaling pathway remains unclear, although the present study has demonstrated that the V protein can regulate cell proliferation through the Wnt/beta-catenin signaling pathway.

Studies have shown that absence of the V protein may be an important measure to transform oncolytic viruses [28], and this finding does not contradict our findings, which indicate that the V protein promotes cell proliferation through multiple signaling pathways. In the future, more efficient oncolytic viruses may be obtained based on modification of the V protein.

Conclusions

A well-understood phenomenon is the ability of oncolytic NDV to inhibit cancer cell proliferation. As a nonstructural protein of NDV, the V protein mainly plays a role in promoting virus replication, but our results show that the V protein can promote cancer cell proliferation at the single-cell level. This finding may suggest the idea of oncolytic virus transformation. Moreover, through transcriptome sequencing, we initially found some mechanisms by which the V protein promotes the proliferation of cancer cells, which may provide a new solution for better use of Newcastle disease virus for oncolysis. When killing cancer cells with viruses, it may be a good choice to delete the V protein from the viruses.

Materials and methods

Cell culture and virus

The HepG2 cells used in this experiment had been previously obtained and were stored in our laboratory (Shanghai EK-Bioscience Biotechnology Co., Ltd.). All cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Thermo, Waltham, USA) supplemented with 10% fetal bovine serum (FBS; Gibco, Grand Island, USA) (2% FBS was used in the maintenance culture medium), 100 U/mL penicillin, 0.1 mg/mL streptomycin, 2 mM/L-glutamine (Invitrogen, Carlsbad, CA, USA), and 1% nonessential amino acids (Invitrogen, Carlsbad, CA, USA).

La Sota is an attenuated NDV strain that had been previously obtained and was stored in our laboratory. Viruses were propagated in the allantoic cavities of 9–11-day-old embryo-specific-pathogen-free chicken eggs, and the allantoic fluid was harvested and stored at − 70 °C until further use [10].

Vector construction

The full-length V gene was amplified from NDV-infected cells and inserted into pCAGEN-Flag to generate pCAGEN-Flag-V. The sequences of the primers used are listed in sequence Table 1.

Table 1 Primers sequence
Full size table

Transfection and viral infection

Kemix-TRLIP was used for plasmid transfection of HepG2 cells. After reaching a density of 60%, the cells were transfected. To overexpress the V protein, cells were transfected with pCAGEN-Flag-V, and the control cells were transfected with an empty pCAGEN-Flag plasmid. To examine the influence of V on cell proliferation, 24–48 h after transfection of the cells with the plasmid encoding the V protein, samples were collected for further analysis. At the appropriate time, whole RNA was collected and stored until further analysis.

Flow cytometry

From 24 to 48 h posttransfection with pCAGEN-Flag-V, the number of apoptotic cells was detected by propidium iodide (PI) staining assay according to the manufacturer’s protocol. Briefly, 1 × 106 cells were harvested and washed twice with PBS, fixed with precooled 75% alcohol for 2 h, washed twice with PBS, and incubated with 10 µl of PI in the dark for 30 min. The cells were analyzed with a FACSCalibur instrument (CytoFLEX, Beckman Coulter).

Immunofluorescence analyses and EdU analysis

Cells were transfected with pCAGEN-Flag-V. Forty-eight hours later, 10 Nm EdU was added to the cultures and incubated for 1 h. The assay steps were performed according to the respective manufacturer’s instructions. Briefly, the cells were treated with paraformaldehyde solution, 0.3% Triton X-100, primary antibody (anti-Flag, CST, # 14793S, 1:200 for immunofluorescence; anti-NDV (chicken immune serum) polyclonal antibody, prepared in our laboratory, 1:1000 for immunofluorescence), Click additive solution, secondary antibody (goat anti-rabbit IgG H&L (Alexa Fluor® 488), Abcam, ab150077, 1:300 for immunofluorescence; goat anti-chicken IgY H&L (Alexa Fluor® 488), Abcam, ab150169, 1:300 for immunofluorescence) and Hoechst 33,342. Between every step, the cells were washed with PBS three times.

RNA-seq and qRT–PCR

After overexpressing the V protein in HepG2 cells, total RNA was isolated with RNAiso Plus (Takara, Code No.: 9109). Sequencing libraries were generated using the NEBNext® UltraTM RNA Library Prep Kit for Illumina® (NEB, USA) following the manufacturer’s recommendations, and index codes were added to attribute sequences to each sample. The samples were sequenced with an Illumina HiSeq 4000 system (Illumina Inc., USA). Differential expression of transcripts in the treatment and control groups was measured. RNA-Seq was performed by BGI Co., and differentially expressed genes were identified with the linear models for microarray data (limma) package in GEO2R; the cutoff criteria were P < 0.05.

After overexpressing the V protein in HepG2 cells, the relative mRNA expression of C-Myc, ATF1, c-Fos, CCND1, NDV vRNA and C1QC was measured by qRT–PCR. The cells were lysed with TRIzol reagent (TaKaRa, Dalian, China) to obtain total cellular RNA. Subsequently, cDNA was synthesized by reverse transcription using the Prime Script RT reagent kit (TaKaRa, Dalian, China). qRT–PCR was performed with RealStar Green Fast Mixture (GenStar, Beijing, China) according to the manufacturer’s protocol. β-Actin was the internal control, and the relative expression of each gene was normalized to that of β-actin. Relative transcript levels were analyzed using the 2-△△T method. The sequences of the qRT–PCR primers are listed in Table 1.

Real-time label-free cell recorder detection

A total of 10,000 cells per well were seeded on 16-well E-pates, and cell growth was recorded every 15 min for 96 h. Two hours after seeding the cells, a mixture consisting of a protein V expression vector and transfection reagent was added to the cells. Then, 0.2 µg of plasmid and 0.5 µl of transfection reagent were added to each well. After continuous recording, the experiments were replicated, and the results were analyzed.

Statistical analysis

Statistical analysis was performed with GraphPad Prism 5 software (GraphPad Software, Inc., CA, USA). All values are expressed as the means ± SDs of three independent experiments. Student's t test and one-way ANOVA were used to evaluate the significance of differences; P < 0.05 was considered to be statistically significant.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

The raw data from both the mRNA and miRNA sequencing were submitted to the GEO of NCBI with accession number PRJNA871355 for the mRNA datahttps://www.ncbi.nlm.nih.gov/sra/PRJNA871355).

References

  1. Vannini A, Leoni V, Campadelli-Fiume G. Targeted delivery of IL-12 adjuvants immunotherapy by oncolytic viruses. Adv Exp Med Biol. 2021;1290:67–80.

    Article  CAS  PubMed  Google Scholar 

  2. Steward M, Vipond IB, Millar NS, Emmerson PT. RNA editing in Newcastle disease virus. J Gen Virol. 1993;74(Pt 12):2539–47.

    Article  CAS  PubMed  Google Scholar 

  3. Huang Z, Liu M, Huang Y. Oncolytic therapy and gene therapy for cancer: recent advances in antitumor effects of Newcastle disease virus. Discov Med. 2020;30(159):39–48.

    PubMed  Google Scholar 

  4. Mirza AM, Iorio RM. A mutation in the stalk of the newcastle disease virus hemagglutinin-neuraminidase (HN) protein prevents triggering of the F protein despite allowing efficient HN-F complex formation. J Virol. 2013;87(15):8813–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Battisti AJ, Meng G, Winkler DC, McGinnes LW, Plevka P, Steven AC, et al. Structure and assembly of a paramyxovirus matrix protein. Proc Natl Acad Sci U S A. 2012;109(35):13996–4000.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Elankumaran Subbiah, Rockemann Daniel, Samal Siba, et al. Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death. J Virol. 2006;80:7522.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Chu Z, Wang C, Tang Q, Shi X, Gao X, Ma J, et al. Newcastle disease virus V protein inhibits cell apoptosis and promotes viral replication by targeting CacyBP/SIP. Front Cell Infect Microbiol. 2018;8:304.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Wang C, Chu Z, Liu W, Pang Y, Gao X, Tang Q, et al. Newcastle disease virus V protein inhibits apoptosis in DF-1 cells by downregulating TXNL1. Vet Res. 2018;49(1):102.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Park MS, Shaw ML, Munoz-Jordan J, Cros JF, Nakaya T, Bouvier N, et al. Newcastle Disease Virus (NDV)-Based assay demonstrates interferon-antagonist activity for the NDV V Protein and the Nipah Virus V, W, and C Proteins. J Virol. 2003;77:1501.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Chu Zhili, Ma Jiangang, Wang Caiying, Lu Kejia, et al. Newcastle disease virus V Protein promotes viral replication in hela cells through the activation of MEK/ERK Signaling. Viruses. 2018;10:489.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Wang X, Jia Y, Ren J, Huo N, Liu H, Xiao S, et al. Newcastle disease virus nonstructural V Protein upregulates SOCS3 expression to facilitate viral replication depending on the MEK/ERK pathway. Front Cell Infect Microbiol. 2019;9:317.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Chang L, Karin Micheal. Mammalian MAP kinase signalling cascades. Nature. 2001;41:37.

    Article  Google Scholar 

  13. Barbosa R, Acevedo LA, Marmorstein R. The MEK/ERK network as a therapeutic target in human cancer. Mol Cancer Res. 2021;19(3):361–74.

    Article  CAS  PubMed  Google Scholar 

  14. Chanthavixay G, Kern C, Wang Y, Saelao P, Zhou H. Integrated transcriptome and histone modification analysis reveals NDV Infection under heat stress affects bursa development and proliferation in susceptible chicken line. Front Genet. 2020;11: 567812.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Fu LN, Wei Z, Wen LN, Tong Y, Ning YJ. Newcastle disease virus inhibits the proliferation of T cells induced by dendritic cells in vitro and in vivo. Front Immunol. 2021;11: 619829.

    Article  Google Scholar 

  16. Mk A, Asmn B, Me A, Bs A, Dm C, Hk A, et al. Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis - ScienceDirect. Saudi J Biol Sci. 2020;27(1):47–52.

    Article  Google Scholar 

  17. Jafri Malin, Abdullah Zulkifli, Mustafa Aini, et al. Newcastle disease virus interaction in targeted therapy against proliferation and invasion pathways of glioblastoma multiforme. Biomed Res Int. 2014;22014:386470.

    Google Scholar 

  18. Asmn A, Ff B, Pm B, Mk C, Mya D, Ag B. Oncolytic effects of Hitchner B1 strain of newcastle disease virus against cervical cancer cell proliferation is mediated by the increased expression of cytochrome C, autophagy and apoptotic pathways - ScienceDirect. Microbial Pathogenesis. 2020;147:104438.

    Article  Google Scholar 

  19. Chu Z, Gao X, Liu H, Ma J, Wang C, Lu K, et al. Newcastle disease virus selectively infects dividing cells and promotes viral proliferation. Vet Res. 2019;50(1):27.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Martin CK, Samolej J, Olson AT, Bertoli C, Wiebe MS, de Bruin RAM, et al. Vaccinia virus arrests and shifts the cell cycle. Viruses. 2022;14(2):431.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Jie W, Rui-Fen Z, Zhong-Xiang H, Yan W, Wei-Na L, Yong-Ping M, et al. Inhibition of cell proliferation by Tas of foamy viruses through cell cycle arrest or apoptosis underlines the different mechanisms of virus-host interactions. Virulence. 2022;13(1):342–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Han R, Liang L, Qin T, Xiao S, Liang R. Encephalomyocarditis virus 2A protein inhibited apoptosis by interaction with annexin A2 through JNK/c-Jun pathway. Viruses. 2022;14(2):359.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Lee SA, Ho C, Troxler M, Lin CY, Chung SH. Non-metabolic functions of PKM2 contribute to cervical cancer cell proliferation induced by the HPV16 E7 oncoprotein. Viruses. 2021;13(3):433.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Duronio RJ, Xiong Y. Signaling pathways that control cell proliferation. Cold Spring Harb Perspect Biol. 2013;5(3):a008904.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Hayat R, Manzoor M, Hussain A. Wnt signaling pathway: A comprehensive review. Cell Biol Int. 2022;17(10):11797.

    Google Scholar 

  26. Kasperek A, Béguin A, Bawa O, De Azevedo K, Job B, Massard C, et al. Therapeutic potential of the human endogenous retroviral envelope protein HEMO: a pan-cancer analysis. Mol Oncol. 2022;16(7):1451–73.

    Article  CAS  PubMed  Google Scholar 

  27. Donmez HG, Akgor U, Onder S, Tanacan A, Kuru O, Ozgul N, et al. Impact of human papillomavirus on Wnt/Beta-catenin signaling in morphological inconspicuous cervicovaginal cells. Acta Cytol. 2022;18:1–11.

    Google Scholar 

  28. de Graaf JF, van Nieuwkoop S, Bestebroer T, Groeneveld D, van Eijck CHJ, Fouchier RAM, et al. Optimizing environmental safety and cell-killing potential of oncolytic newcastle disease virus with modifications of the V, F and HN genes. Plos One. 2022;17(2):e0263707.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank the instrument sharing platform at Xinxiang Medical University for assistance with technical support.

Funding

This work was supported by the Key Research and Development Projects of Colleges and Universities in Henan Province (No. 21A320016).

Xinxiang Medical College Talent (PhD) Support Program (No. XYBSKYZZ201919).

Author information

Author notes

  1. Zhili chu and Sihui Yang contributed equally to this work.

Authors and Affiliations

  1. Xinxiang Key Laboratory of Pathogenic Biology, Department of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China

    Zhili Chu, Sihui Yang, Qianru Li, Jianing Shang, Zilong Ren & Feng Ren

  2. Henan International Joint Laboratory of Immunity and Targeted Therapy for liver-intestinal Tumors, Xinxiang Medical University, Xinxiang, China

    Zhili Chu & Feng Ren

Authors
  1. Zhili Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sihui Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qianru Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jianing Shang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zilong Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Feng Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Zhili Chu designed research. Zhili Chu、SihuiYang、Qianru Li、Jianing Shang and Zilong Ren performed research. Zhili Chu and Feng Ren analyzed data. Zhili Chu and Feng Ren wrote the paper. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Zhili Chu or Feng Ren.

Ethics declarations

Ethics approval and consent to participate

Animal testing methods were performed in accordance with relevant guidelines and regulations and handled according to standard use protocols and animal welfare regulations. The protocol in this study was approved by the Committee on the Ethics Committee of Xinxiang Medical (Permit XYLL-2021077). In addition, we confirm that all animal methods are reported in accordance with ARRIVE guidelines (http://arriveguidelines.org).

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chu, Z., Yang, S., Li, Q. et al. The V protein in oncolytic Newcastle disease virus promotes HepG2 hepatoma cell proliferation at the single-cell level. BMC Cancer 23, 346 (2023). https://doi.org/10.1186/s12885-023-10815-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12885-023-10815-4

Keywords

BMC Cancer

ISSN: 1471-2407

Contact us